Safety and immunologic benefits of conversion to sirolimus in kidney transplant recipients with long-term exposure to calcineurin inhibitors

BACKGROUND/AIMS: Sirolimus (SRL) is a promising immunosuppressant replacingcalcineurin inhibitors (CNIs). This study was performed to evaluate the safetyand immunologic benefits of conversion to SRL in stable kidney transplant (KT)recipients exposed to CNIs for long periods. METHODS: Fourteen CNI-tr...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Korean J Intern Med
Main Authors: Yu, Ji Hyun, Kim, Kyoung Woon, Kim, Bo-Mi, Chung, Byung Ha, Cho, Mi-La, Choi, Bum Soon, Park, Cheol Whee, Kim, Yong-Soo, Yang, Chul Woo
Formato: Artigo
Idioma:Inglês
Publicado: The Korean Association of Internal Medicine 2016
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4855095/
https://ncbi.nlm.nih.gov/pubmed/26968190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2014.366
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares